Severe Myelodysplasia with Monosomy 7 Developing during Imatinib Treatment of Philadelphia-Positive Chronic Myeloid Leukemia: Two Cases Evolving with Different Outcome.
José‐Tomás Navarro(Universitat Autònoma de Barcelona), Fuensanta Millá, Evarist Feliú(Universitat Autònoma de Barcelona), Isabel Granada(Josep Carreras Leukaemia Research Institute), Albert Oriol(Institut Català d'Oncologia), Blanca Espinet(Hospital Del Mar), Javier Grau, Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Dolors Colomer(Hospital Clínic de Barcelona), Josep‐María Ribera(Universitat Autònoma de Barcelona), Natàlia Lloveras, Jordi Juncà(Universitat Autònoma de Barcelona), Elisa Orna(Universitat Autònoma de Barcelona)
Cited by 0
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719